[Prophylactic intravesical BCG for bladder tumor after surgery of upper tract urothelial carcinoma].
Nihon Hinyokika Gakkai Zasshi
; 81(12): 1857-60, 1990 Dec.
Article
in Ja
| MEDLINE
| ID: mdl-2292818
ABSTRACT
We report the result of prophylactic intravesical instillation of BCG after surgery of upper tract urothelial carcinoma. The BCG Tokyo 172 strain was given preoperatively and/or postoperatively, as a rule, in a dose of 80 mg in 30 ml saline instilled into the bladder. Only one (14.3%) of the 7 patients with intravesical BCG developed bladder tumor at 14 month after surgery, while (45.4%) of 11 patients who did not receive intravesical BCG suffered from bladder tumor within 2 years after surgery. Prophylactic intravesical instillation of BCG reduced significantly (p less than 0.005) the recurrence of bladder tumor after the surgery of renal pelvis and ureteral tumor.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ureteral Neoplasms
/
Urinary Bladder Neoplasms
/
BCG Vaccine
/
Carcinoma, Transitional Cell
/
Kidney Neoplasms
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
Ja
Journal:
Nihon Hinyokika Gakkai Zasshi
Year:
1990
Document type:
Article